Administration

行政

• 批准号: 7287029
• 负责人: David Piwnica-Worms
• 金额: $ 35.19万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-28 至 2011-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7287029
• 关键词: Area; Biological; Clinical Sciences; Collaborations; Commit; Development; Division of Clinical Sciences; Facility Construction Funding Category; Funding; Genetic; Genomics; Housing; Human; Human Genetics; Image; Institution; Knowledge; Lead; Location; Malignant Neoplasms; Medical center; Molecular and Cellular Biology; Pathway interactions; Patient Care; Prevention; Process; Productivity; Research; Research Personnel; Science; Therapeutic; Translating; Treatment Protocols; Universities; Washington; anticancer research; cancer diagnosis; concept; improved; in vivo; in vivo Cellular and Molecular Imaging Centers; molecular imaging; multidisciplinary; novel; novel diagnostics; programs; success

A.1. Institutional Concept of the Center. We have had remarkable success in developing our ICMIC as the focal point for the development of novel in vivo molecular imaging strategies at Washington University. This has involved reinforcing ongoing collaborations, developing new collaborations and enhancing the productivity of multidisciplinary programs in basic and translational cancer research on campus. The ICMIC has promoted excellence in cancer research by providing a formal process for interdisciplinary interaction. This has not only lead to new information in the cellular and molecular biology of cancer, but also enhanced the pathway toward novel diagnostic and therapeutic regimens. Thus, our NCI-funded Molecular Imaging Center program at Washington University has made documented steps to improve cancer diagnosis, treatment and prevention. One area of institutional impact has been in relation to BioMed 21, an institution-wide strategic research initiative that aims to rapidly translate genomic science into patient care. BioMed 21 has been approved at the highest levels and will reshape the Washington University culture over the next 10 years to rapidly convert the knowledge of the genetic blueprint of human beings into effective, individualized treatments. BioMed 21 establishes three new research units that span both campuses of Washington University: The Center for Genomics and Human Genetics, the Division of Clinical Sciences and importantly, the Center for Biological Imaging. WU has committed to the construction of a 250,000 squarefoot building in the center of the medical campus dedicated to bridge the basic and clinical sciences. The Center for Biological Imaging will be housed in this new building, and our ICMIC program will have a major presence in this initiative, providing the potential to further solidify in one central location our current assembly of dedicated investigators.

A.1.中心的制度概念。 我们在将我们的国际通讯和信息技术委员会发展成为发展的协调中心方面取得了显著的成功。 在华盛顿大学的新的体内分子成像策略。这涉及到加强 持续的合作、开发新的合作并提高多学科的生产力 在校园里进行基础和转化癌症研究的项目。ICMIC促进了以下方面的卓越表现： 癌症研究提供了一个正式的过程，跨学科的互动。这不仅导致 癌症的细胞和分子生物学的新信息，但也增强了通往 新的诊断和治疗方案。因此，我们的国家癌症研究所资助的分子成像中心计划， 华盛顿大学已经采取了有记录的措施来改善癌症的诊断、治疗和 预防 产生机构影响的一个领域是与BioMed 21有关， 该研究计划旨在将基因组科学快速转化为患者护理。BioMed 21已经 在最高层批准，并将重塑华盛顿大学文化在未来10年， 迅速将人类基因蓝图的知识转化为有效的，个性化的， 治疗。生物医学21建立了三个新的研究单位，跨越两个校园的华盛顿 大学：基因组学和人类遗传学中心，临床科学部， 重要的是，生物成像中心。WU承诺建造一个250，000平方英尺的 这座位于医学校园中心的建筑致力于连接基础科学和临床科学。的 生物成像中心将设在这座新大楼里，我们的ICMIC计划将有一个主要的 在这一倡议中的存在，提供了进一步巩固在一个中心位置，我们目前的潜力 专门的调查人员的集合。